Name:
3-Methylfentanyl
Type:
Synthetic opioid
AKA:
China White, fentanyl
3-Methylfentanyl image
Synthetic substance, no natural derivative
IUPAC Logo
3-Methylfentanyl image
3-Methylfentanyl, a potent synthetic opioid, was developed as a fentanyl analog in the late 20th century. Its high potency led to its use in both medical and illicit contexts. The compound has been associated with a significant number of overdose cases, prompting regulatory actions and public health concerns.
Synthetic Substances Image
3-Methylfentanyl is a potent opioid, acting as a depressant with effects including sedation, pain relief, and constricted pupils. It can significantly reduce heart rate and respiratory rate. Short-term use provides strong pain relief, but long-term use can lead to severe addiction, tolerance, and respiratory issues. Overdose risks include fatal respiratory depression. Safe use demands strict medical oversight. Recent research highlights its potency and risks associated with misuse.
N/A
3-Methylfentanyl, an opioid, affects opioid receptors, causing euphoria and cognitive impairment. Immediate effects include mood enhancement and pain relief, lasting several hours. Long-term use can lead to dependence and psychological issues such as depression. Research indicates significant mental health risks with chronic use, including severe mood disturbances and potential for addiction.
N/A
3-Methylfentanyl is a highly potent synthetic opioid, significantly more potent than fentanyl. Its cultural significance lies in its impact on the opioid crisis, particularly its role in overdose deaths. Originally developed for pain management, synthetic opioids like 3-Methylfentanyl have led to widespread misuse and significant public health challenges. Historically, opioids have been used for centuries for pain relief and recreational purposes. The modern misuse of potent opioids has led to high-profile overdoses and ongoing debates about drug policy, harm reduction, and the balance between medical necessity and the risk of abuse. Media coverage often highlights the dangers and regulatory challenges associated with such potent substances.
N/A